Global In-Vitro Diagnostics Enzymes Market to Grow at 7.7% During 2024-2032, Catalyzed by Increasing Incidences of Chronic Diseases

July 04, 2022 | Healthcare

IMARC Group’s latest report, titled “In-Vitro Diagnostics Enzymes Market Report by Enzyme Type (Proteases, Polymerase and Transcriptase, Ribonuclease, and Others), Disease Type (Infectious Disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, and Others), Technology Type (Histology Assays, Molecular Diagnostics, Clinical Chemistry), End Use (Pharma and Biotech Companies, Hospital and Diagnostic Labs, Contract Research Organizations (CROs), and Others), and Region 2024-2032,” finds that the global in-vitro diagnostics enzymes market is expected to exhibit a CAGR of 7.7% during 2024-2032. In-vitro diagnostics (IVD) refer to tests performed on blood and tissue samples taken from the human body. It is widely used to detect diseases and other medical conditions in individuals using assays and reagents. It is also employed for the screening and monitoring of the overall health of patients to help cure, treat, or prevent diseases. These diagnostic solutions utilize enzymes for diagnosing various illnesses due to their excellent biocatalytic properties. Some commonly used IVD enzymes include gelatinase-B, alanine transaminase, creatine kinase, acid phosphatase, aspartate transaminase, and lactate dehydrogenase. In recent years, IVD enzymes have gained immense traction as biomarkers for detecting numerous diseases, including cancer, renal disease, rheumatoid arthritis, myocardial infarction, and schizophrenia.

Global In-Vitro Diagnostics Enzymes Market Trends:

The increasing incidences of chronic and infectious diseases represent the primary factor driving the market growth. Besides this, the growing need for rapid and accurate disease diagnosis has augmented the demand for IVD enzymes. Additionally, polymerase chain reaction (PCR) is gaining popularity across the healthcare industry as it facilitates the easy detection of numerous organisms with higher precision and sensitivity. In line with this, due to the surging cancer cases, the escalating demand for efficient diagnostic solutions that require the usage of enzymes for histopathology of biopsy samples has accelerated the product adoption rate. Apart from this, the rising popularity of IVD techniques in the field of oncology, such as In Situ Hybridization (ISH) and Next-Generation Sequencing (NGS), has catalyzed the market growth. Furthermore, amid the recent coronavirus disease (COVID-19) outbreak, the leading players are developing reagents for detecting antigens for the COVID-19 virus. Along with this, the introduction of enzyme biosensors has expanded the applications of enzymes for the clinical diagnosis of medical conditions, such as tuberculosis, atypical pneumonia, and ulcerative urogenital infections, thereby contributing to the market growth. Other factors, including the rising demand for point-of-care IVD, improving healthcare infrastructure, supportive reimbursement policies, and extensive research and development (R&D) activities, are also creating a favorable market outlook.

Market Summary:

  • Based on the enzyme type, the market has been segregated into proteases, polymerase and transcriptase, ribonuclease, and others.
  • On the basis of the disease type, the market has been classified into infectious disease, diabetes, oncology, cardiology, nephrology, autoimmune diseases, and others. 
  • The market has been divided based on technology type into histology assays, molecular diagnostics, and clinical chemistry. 
  • Based on the end use, the market has been categorized into pharma and biotech companies, hospital and diagnostic labs, contract research organizations (CROs), and others. 
  • Region-wise, the market has been segmented into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has also been analyzed, with some of the key players being Advanced Enzymes Technologies Ltd., Affymetrix (Thermo Fisher Scientific), Amano Enzyme Inc., American Laboratories Inc., Amicogen Inc., BBI Solutions, Biocatalysts Limited (Brain AG), Codexis Inc., Dyadic International Inc., F. Hoffmann-La Roche AG, and Merck KGaA.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Enzyme Type, Disease Type, Technology Type, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Advanced Enzymes Technologies Ltd., Affymetrix (Thermo Fisher Scientific), Amano Enzyme Inc., American Laboratories Inc., Amicogen Inc., BBI Solutions, Biocatalysts Limited (Brain AG), Codexis Inc., Dyadic International Inc., F. Hoffmann-La Roche AG and Merck KGaA
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1 631 791 1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global In-Vitro Diagnostics Enzymes Market to Grow at 7.7% During 2024-2032, Catalyzed by Increasing Incidences of Chronic Diseases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More